New FDA Initiatives Aim to Spur Innovation

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-02-2003
Volume 27
Issue 8

Manufacturers face challenges from FDA's plans to streamline the drug review and development processes aimed to spur innovation.

Recent Videos
CPHI Milan 2024: Compliance and Automation in Aseptic Processing
Related Content